You are viewing a single comment's thread.

view the rest of the comments →

0
2

[–] DuHast 0 points 2 points (+2|-0) ago 

I think the reason hydroxychloroquin as been soft peddled up until now is that the availability of this drug has been very limited. This drug is only used for a small patient cohort. Some rheumatoid arthritis patients and some lupus patients. So the amount of the drug in the pipeline is small. Enough to service these patients. Supplies are now being brought on board.